In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We tested the activities of anidulafungin and other antifungal agents against clinical isolates of different fungal species. For Candida species, high sessile MIC 90 s (SMIC 90 s) were obtained for fluconazole, voriconazole, and amphotericin B, whereas the anidulafungin SMIC 90 s were very low, as were those for caspofungin. Comparatively, for Aspergillus species, higher SMIC 90 values were obtained not only for amphotericin B and voriconazole but also for the echinocandins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041 · cited 2×
“From the resulting colorimetric readings, and after subtraction of the corresponding values for negative controls, the SMICs were calculated and expressed as the lowest drug concentrations at which a 50% decrease in absorbance was detected in comparison with the level for the biofilms formed in the absence of drug (21…”
MethodResultResistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Self-citationOur Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-07 · Cited by 343
Self-citationIn vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269 · cited 1×
“Typical biofilm structures, consisting of fungal mycelium surrounded by an extracellular matrix composed of galactomannan, -1,3-glucans, and melanin (3), were also observed in aspergilloma or during invasive aspergillosis (12).”
BackgroundFungal echinocandin resistance
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267
An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus
Beauvais, A., Schmidt, C., Guadagnini, S., Roux, P., Perret, E., Henry, C., Paris, S., Mallet, A., Prévost, M.-C., & Latgé, J. P. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00895.x · Cited by 262
Mowat, E., Butcher, J., Lang, S., Williams, C., & Ramage, G. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47247-0 · Cited by 259 · cited 2×
“fumigatus, which until now was the only Aspergillus species studied concerning antifungal drug susceptibility under biofilm conditions (3, 15, 16, 23).”
BackgroundGenetic Basis of Candida Biofilm Resistance Due to Drug‐Sequestering Matrix Glucan
Nett, J. E., Sanchez, H., Cain, M. T., & Andes, D. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651200 · Cited by 250 · cited 1×
“A recent study exploring the early transcriptional responses of mature Candida albicans biofilm exposed to various antifungal agents suggests that enhanced extracellularmatrix or beta-glucan synthesis during biofilm growth (18) might prevent fluconazole and amphotericin B from reaching biofilm cells, thus impairing th…”
BackgroundPenetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235 · cited 1×
“parapsilosis biofilm (10) or the rate of drug diffusion through the biofilm (1), also linked to the echinocandin relative hydroTABLE 2.”
BackgroundSeidler, M. J., Salvenmoser, S., & Müller, F.-M. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-08 · Cited by 229 · cited 3×
“fumigatus, which until now was the only Aspergillus species studied concerning antifungal drug susceptibility under biofilm conditions (3, 15, 16, 23).”
BackgroundBiofilm formation in clinical Candida isolates and its association with virulence
Hasan, F., Xess, I., Wang, X., Jain, N., & Fries, B. C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.018 · Cited by 206 · cited 1×
“This antifungal resistance may contribute to the increased pathogenicity of Candida species (2, 7), as observed in catheter-associated bloodstream infections due to biofilm-forming isolates (26).”
BackgroundVediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183 · cited 1×
“A recent study exploring the early transcriptional responses of mature Candida albicans biofilm exposed to various antifungal agents suggests that enhanced extracellularmatrix or beta-glucan synthesis during biofilm growth (18) might prevent fluconazole and amphotericin B from reaching biofilm cells, thus impairing th…”
BackgroundAspergillus fumigatus biofilms in the clinical setting
Müller, F.-M. C., Seidler, M., & Beauvais, A. (2011) · Medical Mycology · doi:10.3109/13693786.2010.502190 · Cited by 123 · cited 1×
“Similar to Candida, filamentous molds such as Aspergillus fumigatus have been shown to be implicated in biofilm-associated infections (17, 22).”
Result
Cited by
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Del Pozo, J. L. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1417036 · Cited by 453
Reactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
Echinocandins in antifungal pharmacotherapy
Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145
Aspergillus biofilms: clinical and industrial significance
Ramage, G., Rajendran, R., Gutierrez-Correa, M., Jones, B., & Williams, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02381.x · Cited by 136
Metadata
- Authors
- Fiori, B., Posteraro, B., Torelli, R., Tumbarello, M., Perlin, D. S., Fadda, G., & Sanguinetti, M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-06
- Volume
- 55
- Issue
- 6
- Pages
- 3031-3035
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2135327236
- Cited by
- 73
- References
- 15
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.